Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer

NCT01558492 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Prostate Cancer

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Weill Medical College of Cornell University